These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9434870)

  • 1. Risk assessment of environmental agents for developmental toxicity: current and emerging approaches.
    Dellarco VL; Kimmel CA
    Mutat Res; 1997 Dec; 396(1-2):205-18. PubMed ID: 9434870
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of developmental abnormalities and deaths after human zygote exposure.
    Siffel C; Czeizel AE
    Mutat Res; 1995 Jun; 334(3):293-300. PubMed ID: 7753093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental toxicity of 1,6-hexamethylene diisocyanate (HDI) in the Sprague-Dawley rat.
    Astroff AB; Sturdivant DW; Lake SG; Shiotsuka RN; Simon GS; Andrews LS
    Teratology; 2000 Oct; 62(4):205-13. PubMed ID: 10992262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental toxicity of carbon black oil in mice.
    Hansen JM; Reynolds PR; Booth GM; Schaalje GB; Seegmiller RE
    Teratology; 2000 Oct; 62(4):227-32. PubMed ID: 10992264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of maternal and developmental toxicity. Proceedings of the consensus workshop. Rockville, Maryland, May 12-14, 1986.
    Teratog Carcinog Mutagen; 1987; 7(3):201-338. PubMed ID: 2888200
    [No Abstract]   [Full Text] [Related]  

  • 6. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB.
    Knudsen TB; Martin MT; Kavlock RJ; Judson RS; Dix DJ; Singh AV
    Reprod Toxicol; 2009 Sep; 28(2):209-19. PubMed ID: 19446433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to defining the relationship of maternal and developmental toxicity.
    Schardein JL
    Teratog Carcinog Mutagen; 1987; 7(3):255-71. PubMed ID: 2888205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dursban revisited: birth defects, U.S. Environmental Protection Agency, and Centers for Disease Control.
    Sherman JD
    Arch Environ Health; 1997; 52(5):332-3. PubMed ID: 9546754
    [No Abstract]   [Full Text] [Related]  

  • 9. Developmental toxicity risk assessment: consensus building, hypothesis formulation, and focused research.
    Kimmel CA
    Drug Metab Rev; 1996; 28(1-2):85-103. PubMed ID: 8744591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental toxicity evaluation of inhaled tertiary amyl methyl ether in mice and rats.
    Welsch F; Elswick B; James RA; Marr MC; Myers CB; Tyl RW
    J Appl Toxicol; 2003; 23(6):387-95. PubMed ID: 14635263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Don't forget the risk of fetal abnormalities caused by alcohol use during pregnancy! Panorama of the injuries, mechanisms, prevention, therapeutic principles].
    Connheim U; Rydberg U
    Lakartidningen; 2000 May; 97(18):2193-7, 2199. PubMed ID: 10850048
    [No Abstract]   [Full Text] [Related]  

  • 12. Malformations due to toxic influences.
    Källén B
    Acta Ophthalmol (Copenh); 1968; 46(3):313-21. PubMed ID: 4884928
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of maternal toxicity in lovastatin-induced developmental toxicity.
    Lankas GR; Cukierski MA; Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study designs for the assessment of male-mediated developmental toxicity.
    Hales BF; Cyr DG
    Adv Exp Med Biol; 2003; 518():271-7. PubMed ID: 12817696
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicity of chronic ayahuasca administration to the pregnant rat: how relevant it is regarding the human, ritual use of ayahuasca?
    Dos Santos RG
    Birth Defects Res B Dev Reprod Toxicol; 2010 Dec; 89(6):533-5; author reply 531-2.. PubMed ID: 21136499
    [No Abstract]   [Full Text] [Related]  

  • 17. Congenital malformations related to occupational reproductive hazards.
    Sever LE
    Occup Med; 1994; 9(3):471-94. PubMed ID: 7831593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The susceptibility of the fetus and child to chemical pollutants. Pediatric aspects: from the embryo through adolescence: special susceptibility and exposure.
    Lowe CU
    Pediatrics; 1974 May; 53(5):779-82. PubMed ID: 4416529
    [No Abstract]   [Full Text] [Related]  

  • 19. Maternal toxicity of nonsteroidal anti-inflammatory drugs as an important factor affecting prenatal development.
    Burdan F; Szumilo J; Klepacz R
    Reprod Toxicol; 2009 Sep; 28(2):239-44. PubMed ID: 19379806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct effects of 6-aminonicotinamide on the developing rat embryo in vitro and in vivo.
    Turbow MM; Chamberlain JG
    Teratology; 1968 Feb; 1(1):103-8. PubMed ID: 4235140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.